Posted on June 25, 2015
Last month, we traveled to Chicago to attend the American Society of Clinical Oncology’s (ASCO) Annual Meeting. This is where the top up-and-coming cancer research from the year is presented to more than 25,000 experts, advocates, doctors, researchers and scientists from around the world. Our very own Dr. Laura Porter attended and has been keeping a close eye as studies and information have continued to be released. When it was announced that one of the most exciting experimental drugs would be accepting applicants for a new study, she immediately flagged this as something we needed to get out ASAP.
Here’s what you need to know:
One of the most exciting presentations from ASCO was the results of a clinical trial for a new colorectal cancer drug called pembrolizumab (Keytruda). This drug was hailed as a breakthrough for a subset of patients with metastatic colorectal cancer (mCRC). Pembrolizumab is a monoclonal antibody, which means it works to restore the body’s immune response to tumor cells, enabling a patient’s own body to kill the cancer. Read more
Posted on June 1, 2015
Big news on the week before National Cancer Survivors Day – we’ve given our Facebook group a fresh makeover and this is your exclusive invitation to be a part of it!
Blue Hope Nation is our rally cry for our community of survivors, patients and family members, where you can post questions, find support, get information and answers, vent and laugh all while finding strength and hope together. You’re not alone!
Posted on May 28, 2015
We love a good dialogue and you came to the table last week when we posted about Sedasys, the computer-assisted personalized sedation system. Did you know that the Sedasys system has been in development for 15 years and has some pretty interesting effectiveness stats? We wanted to send some additional information your way to consider in case your healthcare provider presented this sedation method as an option.
Posted on May 27, 2015
Have you heard of the Removing Barriers to Colorectal Cancer Screening Act? Here’s the lowdown on why it’s important: currently, seniors covered by Medicare have to pay a coinsurance if their physician finds and removes potentially pre-cancerous polyps during a colonoscopy. Can you imagine waking up from a colonoscopy to discover you owe money you weren’t prepared to pay?
Posted on May 18, 2015
Imagine a day when you go in for a colonoscopy and a machine, not a person, sedates you. You may be familiar with this reality if you’ve come across Sedasys—an FDA-approved anesthesiology machine developed by Johnson & Johnson.